Pfizer (PFE) Jefferies Global Healthcare Conference 2026 summary

Leadership vision and company background

• CEO described a personal journey from academia in Greece to a 33-year global career in the pharmaceutical industry, emphasizing adaptability and entrepreneurship.

• The company is characterized as an iconic, purpose-driven pharmaceutical leader with a 177-year legacy and a focus on breakthrough medicines that improve patient lives.

Competitive advantages and global presence

• Maintains the largest manufacturing network in the industry, demonstrated by rapid COVID-19 vaccine production.

• Holds a top-ranked commercial field force and unparalleled R&D capabilities, with subsidiaries and research teams worldwide.

Strategic focus on oncology and acquisitions

• Redirected post-pandemic energy toward advancing cancer treatment, aiming to convert cancer into a chronic disease.

• Invested COVID-19 profits to acquire Seagen, gaining access to a leading ADC platform and a robust oncology pipeline.

• Early results from Seagen’s products, especially Padcev, show transformational impacts on survival rates for bladder cancer.

• Ongoing studies for new lung cancer therapies could yield the company’s largest oncology product.